Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

On The Move Systems Corp. (OMVS): Survey Shows Shared Economy Platform Triggering Uber-style Trucking Platform

On the Move Systems this morning highlighted a new industry forecast that the trucking industry will soon experience an Uber-style transformation, where shared economy platforms and apps, like the one now under development by OMVS, will play an integral component of operations and revenue-generation. The Frost & Sullivan report predicts that by 2025 such platforms […]

Great Basin Scientific, Inc. (GBSN) Building Presence in Molecular Diagnostics Market through Commercialization of Cost-Effective Technologies

Great Basin Scientific is a molecular diagnostics company developing, manufacturing and commercializing breakthrough chip-based technologies that enable cost-effective, reliable infectious disease testing. By focusing on affordability and ease-of-use, the company is working to make molecular testing available to every patient, providing the means for greatly reduced misdiagnoses while significantly limiting the spread of dangerous infectious […]

Why Aquinox Pharmaceuticals (AQXP) Should be on Every Investor’s Radar

Canadian biotech Aquinox Pharmaceuticals (NASDAQ: AQXP) created quite the industry buzz last week when the company reported positive mid-stage trial results for its bladder pain drug, AQX-1125. In addition to meeting secondary endpoints, the LEADERSHIP trial also demonstrated that a high proportion of patients (49%) achieved a clinically meaningful improvement in pain (2 points or […]

Palatin Technologies, Inc. (PTN) Developing Novel Treatment for Condition that Affects 40 Percent of the Female Population

Palatin Technologies, Inc. (NYSE MKT: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need. The company’s leading product candidate, Bremelanotide, is currently set to begin two phase III clinical trials for the treatment of female sexual dysfunction (FSD). Additionally, Palatin’s development pipeline features a […]

Northern Freegold Resources Ltd. (NFRGF) (NFR.CA) Leveraging the Production Potential of the Yukon to Promote Future Growth

Northern Freegold Resources Ltd. (OTC: NFRGF) (VSE: NFR.CA) is a growth-oriented precious metals exploration and development company headquartered in Vancouver, Canada. The company’s primary exploration property, the Freegold Mountain Project, is located in south-central Yukon and covers zones of mineralization that host established inferred gold resources, including an extensive collection of claims staked in recent […]

 

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape

May 9, 2025

A Market Demanding Safer Opioid Solutions The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers […]

Rotate your device 90° to view site.